SACITUZUMAB GOVITECAN

SACITUZUMAB GOVITECAN was reported 4834 times

SACITUZUMAB GOVITECAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMOTHERAPY CYTOKINE PROPHYLAXIS 1 1.0000
1 CHEST WALL RESECTION 1 1.0000
2 TRIPLE NEGATIVE BREAST CANCER 229 0.3403
3 UGT1A1 GENE MUTATION 3 0.2308
4 CAMPYLOBACTER URINARY TRACT INFECTION 1 0.2000
5 CHEMOTHERAPY SIDE EFFECT PROPHYLAXIS 1 0.2000
6 GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL DECREASED 1 0.0909
7 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 16 0.0482
8 CHOLEDOCHOLITHOTOMY 1 0.0455
9 POLYNEUROPATHY IN MALIGNANT DISEASE 3 0.0366
10 NEUTROPENIC COLITIS 59 0.0285
11 ENTERITIS NECROTICANS 1 0.0278
12 CORNEAL EPITHELIOPATHY 1 0.0263
13 DISSEMINATED VARICELLA 1 0.0263
14 HERPES ZOSTER MENINGOMYELITIS 1 0.0233
15 CHOLINERGIC SYNDROME 14 0.0219
16 NEUROSURGERY 4 0.0216
17 BREAST ULCERATION 3 0.0216
18 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0204
19 GASTROINTESTINAL WALL THINNING 1 0.0200
20 HER2 NEGATIVE BREAST CANCER 1 0.0196
21 CATHETER SITE INJURY 4 0.0188
22 GASTRIC ATONY 1 0.0185
23 METASTASES TO GASTROINTESTINAL TRACT 4 0.0166
24 BENIGN FAMILIAL PEMPHIGUS 1 0.0154
25 BREAST HAEMORRHAGE 5 0.0152
26 BLOOD PRESSURE SYSTOLIC 1 0.0135
27 NEUTROPHIL COUNT ABNORMAL 35 0.0124
28 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
29 FLASHBACK 7 0.0121
30 ACUTE HAEMORRHAGIC ULCERATIVE COLITIS 1 0.0116
31 SEPTIC ENCEPHALOPATHY 2 0.0116
32 DISEASE PROGRESSION 1368 0.0115
33 BACTERIAL COLITIS 2 0.0111
34 INTESTINAL METASTASIS 4 0.0110
35 ANGIODYSPLASIA 4 0.0110
36 CATHETER SITE INFLAMMATION 6 0.0107
37 METASTASES TO SKIN 11 0.0106
38 HAEMORRHAGIC HEPATIC CYST 1 0.0105
39 TERMINAL ILEITIS 6 0.0098
40 BLOOD BILIRUBIN ABNORMAL 12 0.0094
41 METASTASES TO MENINGES 21 0.0092
42 DISCONTINUED PRODUCT ADMINISTERED 3 0.0091
43 IMMUNOTOXICITY 1 0.0088
44 ASPARTATE AMINOTRANSFERASE ABNORMAL 13 0.0085
45 WEIGHT FLUCTUATION 87 0.0083
46 METASTASES TO SOFT TISSUE 2 0.0077
47 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 1 0.0075
48 TUMOUR ASSOCIATED FEVER 3 0.0073
49 DAIRY INTOLERANCE 2 0.0071
50 MECHANICAL ILEUS 4 0.0070
51 HAIR GROWTH RATE ABNORMAL 1 0.0068
52 XEROPHTHALMIA 4 0.0068
53 METASTASES TO CENTRAL NERVOUS SYSTEM 87 0.0067
54 GLUCOSE URINE 1 0.0067
55 DUODENAL OBSTRUCTION 2 0.0067
56 INFUSION RELATED HYPERSENSITIVITY REACTION 4 0.0067
57 BREAST INFLAMMATION 2 0.0065
58 BLADDER SPHINCTER ATONY 1 0.0065
59 PERIORAL DERMATITIS 4 0.0063
60 DISTAL INTESTINAL OBSTRUCTION SYNDROME 2 0.0059
61 FEBRILE BONE MARROW APLASIA 25 0.0059
62 HAEMOGLOBINAEMIA 1 0.0058
63 COLONIC ABSCESS 5 0.0058
64 HEPATITIS CHRONIC ACTIVE 1 0.0058
65 METASTASES TO PLEURA 6 0.0057
66 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
67 DRUG RESISTANCE MUTATION 1 0.0056
68 HERPES ZOSTER MENINGITIS 1 0.0055
69 ENTEROCOLITIS INFECTIOUS 5 0.0054
70 VEIN COLLAPSE 4 0.0052
71 BREAST INDURATION 1 0.0052
72 ONCOLOGIC COMPLICATION 5 0.0052
73 CELL DEATH 10 0.0050
74 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2 0.0049
75 COLONY STIMULATING FACTOR THERAPY 1 0.0048
76 WOUND INFECTION BACTERIAL 2 0.0048
77 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 6 0.0048
78 ADRENOMEGALY 1 0.0048
79 BONE SCAN ABNORMAL 2 0.0047
80 TONGUE COATED 8 0.0046
81 PRODUCT PREPARATION ISSUE 30 0.0046
82 NEUTROPENIC SEPSIS 32 0.0045
83 METASTASES TO LIVER 78 0.0044
84 HAEMOGLOBIN ABNORMAL 28 0.0043
85 AMOEBIASIS 1 0.0043
86 BICYTOPENIA 8 0.0041
87 ILLNESS ANXIETY DISORDER 1 0.0041
88 NEUTROPENIA 549 0.0040
89 METASTASES TO BONE MARROW 2 0.0040
90 PALLIATIVE CARE 6 0.0039
91 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
92 HERPES ZOSTER REACTIVATION 1 0.0038
93 CONJUNCTIVITIS VIRAL 1 0.0038
94 BLOOD CREATININE ABNORMAL 13 0.0038
95 ENTERITIS 24 0.0037
96 STEATOHEPATITIS 2 0.0037
97 EPIGLOTTITIS 2 0.0037
98 HORMONE RECEPTOR POSITIVE BREAST CANCER 1 0.0037
99 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
100 GASTROENTERITIS ESCHERICHIA COLI 2 0.0037
101 ENTEROCOLITIS 21 0.0036
102 BREAST CANCER METASTATIC 39 0.0036
103 NEUTROPHIL COUNT DECREASED 148 0.0036
104 RECALL PHENOMENON 3 0.0036
105 PRERENAL FAILURE 5 0.0035
106 RADIATION NECROSIS 2 0.0035
107 INTERNATIONAL NORMALISED RATIO ABNORMAL 12 0.0035
108 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
109 RETROPERITONEAL FIBROSIS 2 0.0034
110 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
111 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
112 FEBRILE NEUTROPENIA 219 0.0033
113 GRANULOCYTE COUNT DECREASED 6 0.0032
114 DEVICE INFUSION ISSUE 8 0.0032
115 CONGENITAL APLASIA 1 0.0032
116 PLEURAL DISORDER 2 0.0032
117 GASTROINTESTINAL TOXICITY 15 0.0031
118 HAEMATOLOGY TEST ABNORMAL 1 0.0031
119 METASTASES TO LUNG 36 0.0031
120 GENERAL PHYSICAL CONDITION ABNORMAL 21 0.0031
121 APLASIA 6 0.0031
122 ALOPECIA TOTALIS 1 0.0030
123 MALIGNANT PLEURAL EFFUSION 5 0.0030
124 FLUID REPLACEMENT 1 0.0030
125 BREAST CANCER RECURRENT 9 0.0028
126 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
127 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
128 IMPLANT SITE RASH 1 0.0028
129 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
130 PNEUMONITIS 73 0.0027
131 ARTERIAL INJURY 2 0.0027
132 HYDROURETER 1 0.0026
133 DIABETIC KETOSIS 1 0.0026
134 HAEMATOTOXICITY 25 0.0026
135 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
136 HERPES SIMPLEX REACTIVATION 1 0.0026
137 BILE DUCT STENT INSERTION 1 0.0026
138 MALIGNANT ASCITES 2 0.0026
139 MYELOSUPPRESSION 94 0.0026
140 BONE MARROW INFILTRATION 1 0.0026
141 URETERIC STENOSIS 2 0.0025
142 LYMPHANGITIS 2 0.0025
143 PERFORATION 2 0.0025
144 GENITAL ABSCESS 1 0.0025
145 NECROTISING COLITIS 3 0.0024
146 GLUCOCORTICOID DEFICIENCY 1 0.0024
147 CANCER PAIN 6 0.0023
148 HEPATIC CANCER METASTATIC 2 0.0023
149 ANAL SPHINCTER ATONY 1 0.0023
150 METASTASES TO BONE 38 0.0023
151 COUNTERFEIT PRODUCT ADMINISTERED 3 0.0023
152 MASTECTOMY 4 0.0023
153 CONGESTIVE HEPATOPATHY 1 0.0022
154 HEPATIC ENZYME DECREASED 1 0.0022
155 LYMPHOEDEMA 15 0.0022
156 COLITIS 82 0.0022
157 HEART RATE ABNORMAL 12 0.0021
158 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 1 0.0021
159 METASTASIS 15 0.0021
160 RADIOTHERAPY 4 0.0021
161 CELL MARKER INCREASED 1 0.0021
162 INVESTIGATION ABNORMAL 3 0.0021
163 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
164 IMMUNE-MEDIATED DERMATITIS 2 0.0020
165 BRAIN NEOPLASM BENIGN 1 0.0020
166 METASTASES TO LYMPH NODES 13 0.0019
167 TUMOUR NECROSIS 2 0.0019
168 RADIATION INJURY 2 0.0019
169 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
170 ENERGY INCREASED 11 0.0019
171 EPHELIDES 1 0.0019
172 BLEEDING VARICOSE VEIN 1 0.0018
173 FACE INJURY 7 0.0018
174 TUMOUR PSEUDOPROGRESSION 2 0.0018
175 METASTASES TO SPINE 6 0.0018
176 APNOEIC ATTACK 1 0.0018
177 BURN ORAL CAVITY 1 0.0017
178 HAIR GROWTH ABNORMAL 12 0.0017
179 FORMICATION 12 0.0017
180 ELECTROLYTE IMBALANCE 20 0.0017
181 BREAST DISCHARGE 3 0.0017
182 DOSE CALCULATION ERROR 1 0.0017
183 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
184 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
185 TUMOUR MARKER INCREASED 8 0.0017
186 PHARYNGEAL INFLAMMATION 2 0.0016
187 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
188 LARGE INTESTINE INFECTION 2 0.0016
189 XEROSIS 2 0.0016
190 HEPATOBILIARY DISEASE 1 0.0016
191 CATHETER SITE INFECTION 6 0.0016
192 ANAL INFLAMMATION 1 0.0016
193 MUCOSAL INFLAMMATION 41 0.0016
194 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
195 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
196 HYPOVOLAEMIA 9 0.0015
197 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
198 HYPOPHYSITIS 3 0.0015
199 ABSCESS NECK 1 0.0015
200 CYTOPENIA 18 0.0015
201 URETERIC OBSTRUCTION 2 0.0015
202 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
203 GLASSY EYES 1 0.0014
204 SEPTIC SHOCK 61 0.0014
205 TUMOUR HAEMORRHAGE 4 0.0014
206 ERYSIPELAS 7 0.0014
207 HEPATIC LESION 6 0.0014
208 NOROVIRUS INFECTION 2 0.0014
209 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
210 PULMONARY SEPSIS 2 0.0014
211 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
212 TEMPERATURE REGULATION DISORDER 3 0.0013
213 THERAPY PARTIAL RESPONDER 21 0.0013
214 ILEUS PARALYTIC 6 0.0013
215 LARGE INTESTINAL OBSTRUCTION 3 0.0013
216 HEPATIC CYTOLYSIS 17 0.0013
217 GINGIVAL ABSCESS 1 0.0013
218 BRONCHITIS BACTERIAL 1 0.0013
219 THROMBOCYTOPENIA 147 0.0013
220 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
221 ASPIRATION PLEURAL CAVITY 1 0.0013
222 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
223 PORTAL HYPERTENSION 4 0.0013
224 NEOPLASM SKIN 2 0.0013
225 ESCHERICHIA BACTERAEMIA 3 0.0013
226 FUNGAEMIA 2 0.0013
227 OSTEOSCLEROSIS 2 0.0013
228 COLITIS MICROSCOPIC 6 0.0013
229 HYPOVOLAEMIC SHOCK 6 0.0013
230 BLOOD DISORDER 10 0.0012
231 HERPES ZOSTER DISSEMINATED 1 0.0012
232 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
233 BACTERIAL SEPSIS 4 0.0012
234 SARS-COV-2 TEST POSITIVE 16 0.0012
235 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
236 INTERSTITIAL LUNG DISEASE 57 0.0012
237 PRODUCT COLOUR ISSUE 6 0.0012
238 PRODUCT PREPARATION ERROR 24 0.0012
239 HEPATIC HAEMORRHAGE 1 0.0012
240 BLOOD MAGNESIUM DECREASED 10 0.0012
241 PANCYTOPENIA 64 0.0011
242 PSEUDOMONAL SEPSIS 2 0.0011
243 ABDOMINAL SEPSIS 1 0.0011
244 LIVER FUNCTION TEST INCREASED 24 0.0011
245 CANDIDA SEPSIS 1 0.0011
246 CATHETER MANAGEMENT 1 0.0011
247 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
248 TOOTH FRACTURE 12 0.0011
249 SMALL INTESTINAL PERFORATION 2 0.0011
250 ASCITES 31 0.0011
251 HYPOPROTEINAEMIA 2 0.0011
252 DUODENAL PERFORATION 1 0.0010
253 DEVICE RELATED THROMBOSIS 1 0.0010
254 STAPHYLOCOCCAL SEPSIS 5 0.0010
255 PNEUMOTHORAX 16 0.0010
256 HYPERTRANSAMINASAEMIA 7 0.0010
257 BLADDER CANCER RECURRENT 1 0.0010
258 THYROIDITIS 3 0.0010
259 GASTRECTOMY 1 0.0010
260 DEVICE RELATED SEPSIS 2 0.0010
261 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
262 HYPERBILIRUBINAEMIA 10 0.0010
263 DIARRHOEA 615 0.0010
264 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 170 0.0009
265 RADIATION PNEUMONITIS 2 0.0009
266 MASS 13 0.0009
267 HEPATIC FAILURE 28 0.0009
268 WHEELCHAIR USER 4 0.0009
269 ALOPECIA 176 0.0009
270 HYPERCALCAEMIA 11 0.0009
271 DISTRIBUTIVE SHOCK 2 0.0009
272 SEPSIS 98 0.0009
273 ARTERIAL HAEMORRHAGE 1 0.0009
274 POOR VENOUS ACCESS 9 0.0009
275 AORTIC THROMBOSIS 1 0.0009
276 LARGE INTESTINE PERFORATION 6 0.0009
277 INFUSION SITE INFECTION 2 0.0009
278 DIARRHOEA HAEMORRHAGIC 8 0.0009
279 EMBOLISM 7 0.0008
280 BACTERAEMIA 10 0.0008
281 BILE DUCT STENOSIS 1 0.0008
282 WHITE BLOOD CELL COUNT DECREASED 90 0.0008
283 CEREBRAL ARTERY EMBOLISM 1 0.0008
284 BLOOD BILIRUBIN INCREASED 22 0.0008
285 AGRANULOCYTOSIS 15 0.0008
286 HEPATIC ENZYME ABNORMAL 4 0.0008
287 NASAL DRYNESS 5 0.0008
288 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
289 PLATELET DISORDER 2 0.0008
290 METASTASES TO PERITONEUM 2 0.0008
291 HYPERTHERMIA 6 0.0008
292 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
293 PLEURAL EFFUSION 47 0.0008
294 PERIORBITAL OEDEMA 4 0.0008
295 ACQUIRED GENE MUTATION 1 0.0008
296 BLOOD LACTIC ACID INCREASED 4 0.0008
297 LUNG OPACITY 2 0.0008
298 HYPOKALAEMIA 35 0.0008
299 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
300 HERPES OPHTHALMIC 1 0.0008
301 EATING DISORDER 16 0.0008
302 BREAST MASS 5 0.0007
303 HYPOPHAGIA 19 0.0007
304 ANAEMIA 141 0.0007
305 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
306 EFFUSION 1 0.0007
307 ORAL FUNGAL INFECTION 2 0.0007
308 ESCHERICHIA INFECTION 6 0.0007
309 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
310 NEOPLASM PROGRESSION 25 0.0007
311 THERAPY CHANGE 7 0.0007
312 ALVEOLITIS 1 0.0007
313 PULMONARY TOXICITY 5 0.0007
314 CHOLECYSTITIS ACUTE 4 0.0007
315 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
316 BREAST CANCER STAGE IV 2 0.0007
317 OESOPHAGEAL STENOSIS 2 0.0007
318 LIVER DISORDER 31 0.0007
319 HEPATIC FUNCTION ABNORMAL 26 0.0007
320 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
321 NEOPLASM 8 0.0007
322 METASTATIC NEOPLASM 3 0.0007
323 BILIARY DILATATION 1 0.0007
324 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
325 HEPATOTOXICITY 15 0.0007
326 AXILLARY PAIN 1 0.0007
327 INFUSION SITE REACTION 2 0.0007
328 METABOLIC ENCEPHALOPATHY 2 0.0007
329 KERATITIS 2 0.0007
330 DYSCHEZIA 2 0.0007
331 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
332 HEART RATE INCREASED 64 0.0006
333 CHOLANGITIS 4 0.0006
334 BRONCHIAL DISORDER 1 0.0006
335 TOOTH EXTRACTION 8 0.0006
336 LEUKOPENIA 32 0.0006
337 SKIN TIGHTNESS 3 0.0006
338 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
339 FEELING JITTERY 12 0.0006
340 MALIGNANT NEOPLASM PROGRESSION 64 0.0006
341 ORGANISING PNEUMONIA 3 0.0006
342 FLUID INTAKE REDUCED 3 0.0006
343 SKIN MASS 4 0.0006
344 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
345 ENTEROBACTER INFECTION 1 0.0006
346 RED BLOOD CELL COUNT DECREASED 17 0.0006
347 COLITIS ISCHAEMIC 4 0.0006
348 HEPATORENAL SYNDROME 1 0.0006
349 CLOSTRIDIAL INFECTION 2 0.0006
350 HEPATIC CYST 2 0.0006
351 CHOLECYSTITIS 7 0.0006
352 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
353 HEPATIC FIBROSIS 2 0.0006
354 FIXED ERUPTION 1 0.0006
355 ASTHENIA 217 0.0006
356 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
357 TONSILLITIS 3 0.0006
358 EXTREMITY NECROSIS 1 0.0006
359 CHOLESTASIS 11 0.0006
360 DEATH 491 0.0006
361 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
362 JAUNDICE CHOLESTATIC 2 0.0006
363 SINUS TACHYCARDIA 8 0.0006
364 ILEUS 7 0.0006
365 ILEAL STENOSIS 1 0.0006
366 BREAST PAIN 6 0.0006
367 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
368 CONSTIPATION 122 0.0006
369 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
370 DISORGANISED SPEECH 1 0.0005
371 CATHETER PLACEMENT 1 0.0005
372 BLADDER SPASM 1 0.0005
373 GRANULOCYTOPENIA 3 0.0005
374 HAEMODYNAMIC INSTABILITY 4 0.0005
375 ARTERIAL DISORDER 1 0.0005
376 HERPES VIRUS INFECTION 3 0.0005
377 PRODUCT LABEL CONFUSION 3 0.0005
378 SPINAL CORD COMPRESSION 2 0.0005
379 INFUSION RELATED REACTION 34 0.0005
380 GASTROINTESTINAL INFLAMMATION 4 0.0005
381 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
382 GENE MUTATION 1 0.0005
383 EMPYEMA 1 0.0005
384 OESOPHAGEAL CANDIDIASIS 2 0.0005
385 ORGAN FAILURE 2 0.0005
386 FULL BLOOD COUNT DECREASED 10 0.0005
387 ILL-DEFINED DISORDER 30 0.0005
388 INTENTIONAL DOSE OMISSION 14 0.0005
389 BREAST DISORDER 1 0.0005
390 CHEST INJURY 1 0.0005
391 IMPAIRED SELF-CARE 1 0.0005
392 ATRIAL TACHYCARDIA 1 0.0005
393 SENSATION OF FOREIGN BODY 4 0.0005
394 CANDIDA INFECTION 8 0.0005
395 MUSCLE ATROPHY 6 0.0005
396 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
397 ABSCESS INTESTINAL 1 0.0005
398 CLOSTRIDIUM TEST POSITIVE 1 0.0005
399 MENINGITIS 3 0.0004
400 CARDIOTOXICITY 4 0.0004
401 MYOSITIS 4 0.0004
402 PRODUCT ADMINISTRATION ERROR 9 0.0004
403 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
404 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
405 PAPILLOEDEMA 2 0.0004
406 BLOOD LOSS ANAEMIA 1 0.0004
407 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
408 VASCULAR DEVICE INFECTION 2 0.0004
409 HYPERGLYCAEMIA 16 0.0004
410 BRAIN NEOPLASM 4 0.0004
411 EYELID DISORDER 1 0.0004
412 FLAT AFFECT 1 0.0004
413 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
414 HYPOMAGNESAEMIA 6 0.0004
415 STOMATITIS 26 0.0004
416 PERFORMANCE STATUS DECREASED 2 0.0004
417 BILIRUBIN CONJUGATED INCREASED 1 0.0004
418 SKIN REACTION 6 0.0004
419 LYMPHOPENIA 6 0.0004
420 THERAPY NON-RESPONDER 19 0.0004
421 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
422 WEIGHT DECREASED 117 0.0004
423 SUBCUTANEOUS ABSCESS 2 0.0004
424 HYPONATRAEMIA 23 0.0004
425 HYPOTHYROIDISM 13 0.0004
426 HEPATOMEGALY 4 0.0004
427 HYPOPHOSPHATAEMIA 3 0.0004
428 CEREBRAL DISORDER 3 0.0004
429 HYDRONEPHROSIS 3 0.0004
430 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
431 NEUROTOXICITY 7 0.0004
432 TOXIC SKIN ERUPTION 4 0.0004
433 BRAIN OEDEMA 5 0.0004
434 DRUG ERUPTION 7 0.0004
435 TROPONIN INCREASED 3 0.0004
436 CARDIOVASCULAR DISORDER 10 0.0004
437 ISCHAEMIC STROKE 7 0.0004
438 ABDOMINAL INFECTION 1 0.0004
439 PROCEDURAL COMPLICATION 3 0.0004
440 ABDOMINAL PAIN 91 0.0004
441 DEVICE RELATED INFECTION 6 0.0004
442 CACHEXIA 2 0.0004
443 CATHETER SITE PAIN 1 0.0004
444 ACUTE MYELOID LEUKAEMIA 6 0.0004
445 PLATELET COUNT DECREASED 41 0.0004
446 TRANSFUSION 4 0.0004
447 HYPOTENSION 76 0.0004
448 DEHYDRATION 50 0.0004
449 ANAL FISSURE 2 0.0004
450 HEPATIC CIRRHOSIS 7 0.0004
451 GINGIVITIS 2 0.0004
452 MUSCLE DISORDER 3 0.0004
453 FOOT FRACTURE 7 0.0004
454 ABDOMINAL RIGIDITY 1 0.0004
455 HYDROCEPHALUS 2 0.0004
456 OESOPHAGITIS 4 0.0004
457 ACUTE RESPIRATORY FAILURE 7 0.0004
458 COAGULOPATHY 6 0.0004
459 TRANSAMINASES INCREASED 8 0.0004
460 STREPTOCOCCAL INFECTION 2 0.0004
461 BONE PAIN 21 0.0004
462 ELECTRIC SHOCK SENSATION 1 0.0004
463 SKIN INFECTION 4 0.0004
464 OXYGEN SATURATION DECREASED 20 0.0004
465 BLOOD TEST ABNORMAL 5 0.0004
466 BLOOD CALCIUM DECREASED 4 0.0004
467 SKIN PLAQUE 3 0.0004
468 NAUSEA 281 0.0004
469 FATIGUE 273 0.0004
470 PRODUCT CONTAINER ISSUE 3 0.0003
471 PYELONEPHRITIS 3 0.0003
472 ESCHERICHIA SEPSIS 1 0.0003
473 BONE MARROW FAILURE 7 0.0003
474 STRESS CARDIOMYOPATHY 2 0.0003
475 LIVER FUNCTION TEST ABNORMAL 10 0.0003
476 BILIARY COLIC 1 0.0003
477 SPINAL PAIN 4 0.0003
478 TUMOUR LYSIS SYNDROME 3 0.0003
479 HYPOXIA 12 0.0003
480 HYPERCHLORHYDRIA 2 0.0003
481 LUNG INFILTRATION 3 0.0003
482 HEPATITIS FULMINANT 1 0.0003
483 PLEURISY 2 0.0003
484 CEREBRAL HAEMORRHAGE 12 0.0003
485 WEIGHT INCREASED 75 0.0003
486 ACNE CYSTIC 1 0.0003
487 CENTRAL VENOUS CATHETERISATION 1 0.0003
488 BONE MARROW DISORDER 1 0.0003
489 PLATELET COUNT ABNORMAL 2 0.0003
490 COVID-19 58 0.0003
491 DECREASED APPETITE 76 0.0003
492 DYSPHAGIA 31 0.0003
493 CARDIOMEGALY 4 0.0003
494 FIBROSIS 1 0.0003
495 SMALL INTESTINAL OBSTRUCTION 4 0.0003
496 GENERALISED OEDEMA 4 0.0003
497 PHARYNGITIS 4 0.0003
498 INFUSION SITE EXTRAVASATION 2 0.0003
499 PYREXIA 111 0.0003
500 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
501 PHOTOPSIA 2 0.0003
502 NEUROPATHY PERIPHERAL 30 0.0003
503 GLOSSODYNIA 7 0.0003
504 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
505 VOMITING 145 0.0003
506 HEPATITIS ACUTE 2 0.0003
507 RESPIRATORY TRACT INFECTION 8 0.0003
508 HEPATIC NEOPLASM 1 0.0003
509 LABORATORY TEST ABNORMAL 9 0.0003
510 ORAL CANDIDIASIS 4 0.0003
511 MUSCLE TWITCHING 7 0.0003
512 MALAISE 133 0.0003
513 PERICARDIAL EFFUSION 7 0.0003
514 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
515 SOPOR 4 0.0003
516 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
517 CARDIAC FAILURE ACUTE 2 0.0003
518 GAIT INABILITY 10 0.0003
519 TERMINAL STATE 2 0.0003
520 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
521 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
522 HERPES ZOSTER 17 0.0003
523 TASTE DISORDER 6 0.0003
524 HEMIPARESIS 5 0.0003
525 DISCOMFORT 18 0.0003
526 HEPATIC ENZYME INCREASED 20 0.0003
527 EMOTIONAL DISORDER 9 0.0003
528 ECCHYMOSIS 2 0.0003
529 BLOOD PRESSURE FLUCTUATION 7 0.0003
530 RESPIRATORY DISTRESS 8 0.0003
531 NEURALGIA 7 0.0003
532 MOUTH ULCERATION 6 0.0003
533 BRONCHIOLITIS 1 0.0003
534 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
535 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
536 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
537 RETCHING 6 0.0003
538 DEVICE PLACEMENT ISSUE 1 0.0003
539 DECREASED ACTIVITY 3 0.0003
540 CELLULITIS 14 0.0003
541 ABDOMINAL PAIN LOWER 7 0.0003
542 DERMATITIS BULLOUS 2 0.0003
543 OSTEOMYELITIS 5 0.0003
544 FAECES SOFT 2 0.0003
545 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
546 GASTROENTERITIS 4 0.0003
547 WOUND INFECTION 3 0.0003
548 ASTHMATIC CRISIS 1 0.0003
549 PULMONARY EMBOLISM 26 0.0003
550 BLOOD PHOSPHORUS DECREASED 1 0.0003
551 ORAL DISORDER 2 0.0003
552 DRUG RESISTANCE 7 0.0003
553 SENSITIVE SKIN 2 0.0003
554 CARDIAC DYSFUNCTION 1 0.0003
555 PULMONARY MASS 4 0.0003
556 IMMUNODEFICIENCY 4 0.0003
557 MALNUTRITION 3 0.0003
558 ACUTE KIDNEY INJURY 41 0.0003
559 SEDATION 7 0.0003
560 SPEECH DISORDER 14 0.0003
561 HEPATIC NECROSIS 1 0.0003
562 AUTOIMMUNE THYROIDITIS 1 0.0003
563 HYPOCALCAEMIA 5 0.0003
564 DERMATITIS CONTACT 3 0.0003
565 HAEMOGLOBIN DECREASED 27 0.0003
566 MYOCARDITIS 3 0.0003
567 EPILEPSY 8 0.0003
568 BOWEL MOVEMENT IRREGULARITY 2 0.0003
569 CLAVICLE FRACTURE 1 0.0003
570 JAUNDICE 7 0.0003
571 PAIN OF SKIN 7 0.0003
572 MADAROSIS 3 0.0003
573 APHTHOUS ULCER 2 0.0003
574 EJECTION FRACTION DECREASED 4 0.0003
575 FAECES HARD 1 0.0003
576 HAEMORRHOIDS 5 0.0003
577 NERVOUS SYSTEM DISORDER 8 0.0003
578 CERVIX CARCINOMA 1 0.0003
579 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
580 COVID-19 PNEUMONIA 3 0.0003
581 NASAL DISCOMFORT 2 0.0003
582 PRODUCTIVE COUGH 12 0.0003
583 BLEPHARITIS 1 0.0002
584 CYSTITIS HAEMORRHAGIC 1 0.0002
585 STENT PLACEMENT 2 0.0002
586 THROAT IRRITATION 11 0.0002
587 ABNORMAL FAECES 2 0.0002
588 ARTHRITIS BACTERIAL 1 0.0002
589 EXTRAVASATION 1 0.0002
590 GASTROINTESTINAL PERFORATION 1 0.0002
591 SECOND PRIMARY MALIGNANCY 2 0.0002
592 PRODUCT STORAGE ERROR 21 0.0002
593 URINARY RETENTION 8 0.0002
594 INTESTINAL OBSTRUCTION 9 0.0002
595 OFF LABEL USE 207 0.0002
596 TACHYCARDIA 21 0.0002
597 HYPERPYREXIA 1 0.0002
598 ABSCESS LIMB 1 0.0002
599 HEPATIC PAIN 1 0.0002
600 SEIZURE 27 0.0002
601 SCAR 4 0.0002
602 SKIN HYPERPIGMENTATION 2 0.0002
603 ANAPHYLACTIC SHOCK 6 0.0002
604 PRODUCT DISPENSING ERROR 5 0.0002
605 IMMUNE SYSTEM DISORDER 3 0.0002
606 COLD SWEAT 4 0.0002
607 RESPIRATORY RATE INCREASED 2 0.0002
608 BRAIN NEOPLASM MALIGNANT 1 0.0002
609 ABDOMINAL PAIN UPPER 46 0.0002
610 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
611 FREQUENT BOWEL MOVEMENTS 6 0.0002
612 CYSTITIS 7 0.0002
613 EAR DISORDER 1 0.0002
614 UROSEPSIS 2 0.0002
615 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
616 BLOOD GLUCOSE ABNORMAL 4 0.0002
617 DIVERTICULITIS 6 0.0002
618 FEELING OF DESPAIR 1 0.0002
619 BACTERIAL INFECTION 4 0.0002
620 APPENDICITIS 2 0.0002
621 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
622 PNEUMONIA 69 0.0002
623 HEPATOCELLULAR INJURY 3 0.0002
624 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
625 DISEASE RECURRENCE 10 0.0002
626 CARDIOGENIC SHOCK 3 0.0002
627 SOMNOLENCE 42 0.0002
628 COUGH 58 0.0002
629 HYPOKINESIA 3 0.0002
630 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
631 OROPHARYNGEAL PAIN 19 0.0002
632 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
633 HYPERTENSION 43 0.0002
634 HOSPICE CARE 2 0.0002
635 HYPERVOLAEMIA 1 0.0002
636 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
637 HYPERNATRAEMIA 1 0.0002
638 INFECTION 29 0.0002
639 PNEUMONIA ASPIRATION 5 0.0002
640 BRAIN INJURY 2 0.0002
641 THERAPEUTIC RESPONSE DECREASED 12 0.0002
642 LYMPHADENOPATHY 7 0.0002
643 DRUG TOLERANCE 1 0.0002
644 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
645 DYSLIPIDAEMIA 1 0.0002
646 AMMONIA INCREASED 1 0.0002
647 DEVICE ADHESION ISSUE 3 0.0002
648 THYROID DISORDER 3 0.0002
649 HELICOBACTER INFECTION 2 0.0002
650 SKIN ULCER 5 0.0002
651 FAILURE TO THRIVE 1 0.0002
652 DIPLOPIA 5 0.0002
653 C-REACTIVE PROTEIN INCREASED 7 0.0002
654 FOLLICULITIS 2 0.0002
655 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
656 SUDDEN DEATH 2 0.0002
657 RENAL PAIN 2 0.0002
658 RASH 81 0.0002
659 SKIN CANCER 4 0.0002
660 ANAL ABSCESS 1 0.0002
661 BEHAVIOUR DISORDER 1 0.0002
662 CHEILITIS 1 0.0002
663 ERYTHEMA OF EYELID 1 0.0002
664 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
665 BLOOD CREATININE INCREASED 12 0.0002
666 FAECALOMA 1 0.0002
667 BREAST CANCER 17 0.0002
668 SKIN LESION 5 0.0002
669 GASTROINTESTINAL PAIN 2 0.0002
670 PHOTOSENSITIVITY REACTION 3 0.0002
671 DRUG LEVEL INCREASED 3 0.0002
672 RENAL FAILURE 24 0.0002
673 EXPIRED PRODUCT ADMINISTERED 6 0.0002
674 VERTIGO 11 0.0002
675 SYNCOPE 18 0.0002
676 BLOOD UREA INCREASED 3 0.0002
677 RESPIRATORY FAILURE 13 0.0002
678 FACE OEDEMA 3 0.0002
679 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
680 DYSPNOEA 99 0.0002
681 THROMBOSIS 14 0.0002
682 SHOCK 4 0.0002
683 GASTRIC HAEMORRHAGE 2 0.0002
684 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
685 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
686 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
687 POLYNEUROPATHY 2 0.0002
688 HYPERSENSITIVITY 31 0.0002
689 BLOOD POTASSIUM DECREASED 5 0.0002
690 RASH PRURITIC 9 0.0002
691 BLOOD PRESSURE DECREASED 11 0.0002
692 LOCALISED INFECTION 4 0.0002
693 PELVIC PAIN 3 0.0002
694 PRODUCT USE ISSUE 31 0.0002
695 DERMATITIS ACNEIFORM 1 0.0002
696 LUNG DISORDER 8 0.0002
697 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
698 DYSPEPSIA 16 0.0002
699 INJECTION SITE EXTRAVASATION 2 0.0002
700 EPISTAXIS 12 0.0002
701 SECRETION DISCHARGE 2 0.0002
702 FRACTURE 3 0.0002
703 HEPATITIS 4 0.0002
704 EAR PAIN 3 0.0002
705 ORAL HERPES 3 0.0002
706 URINARY TRACT INFECTION 26 0.0002
707 ASPERGILLUS INFECTION 1 0.0002
708 BEDRIDDEN 2 0.0002
709 CORONAVIRUS INFECTION 1 0.0002
710 DYSGEUSIA 11 0.0001
711 SINUS CONGESTION 2 0.0001
712 FEEDING DISORDER 3 0.0001
713 ABNORMAL LOSS OF WEIGHT 1 0.0001
714 ACUTE HEPATIC FAILURE 2 0.0001
715 EYE MOVEMENT DISORDER 1 0.0001
716 ILLNESS 15 0.0001
717 CHILLS 17 0.0001
718 PERITONITIS 3 0.0001
719 ANAPHYLACTIC REACTION 8 0.0001
720 CARDIO-RESPIRATORY ARREST 6 0.0001
721 WOUND 4 0.0001
722 RASH MACULAR 5 0.0001
723 DEVICE OCCLUSION 2 0.0001
724 BRONCHOSPASM 2 0.0001
725 ANGINA PECTORIS 4 0.0001
726 HYPERSOMNIA 4 0.0001
727 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
728 HYPERTHYROIDISM 2 0.0001
729 FLUSHING 14 0.0001
730 PRODUCT PRESCRIBING ISSUE 3 0.0001
731 APATHY 2 0.0001
732 CARDIAC FAILURE 11 0.0001
733 DIZZINESS 68 0.0001
734 DYSURIA 5 0.0001
735 DRY MOUTH 11 0.0001
736 BACK PAIN 31 0.0001
737 DYSPNOEA EXERTIONAL 5 0.0001
738 UNEVALUABLE EVENT 10 0.0001
739 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
740 ACIDOSIS 1 0.0001
741 NASOPHARYNGITIS 24 0.0001
742 MUSCULOSKELETAL CHEST PAIN 2 0.0001
743 CONCUSSION 1 0.0001
744 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
745 HYPOALBUMINAEMIA 1 0.0001
746 COGNITIVE DISORDER 6 0.0001
747 APNOEA 1 0.0001
748 BRAIN FOG 2 0.0001
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
750 DRUG-INDUCED LIVER INJURY 4 0.0001
751 PRODUCT USE COMPLAINT 2 0.0001
752 CHEST DISCOMFORT 13 0.0001
753 BLOOD ALBUMIN DECREASED 1 0.0001
754 MEDICATION ERROR 7 0.0001
755 THERAPY INTERRUPTED 9 0.0001
756 GINGIVAL PAIN 1 0.0001
757 SENSORY DISTURBANCE 2 0.0001
758 ABDOMINAL DISTENSION 13 0.0001
759 FRUSTRATION TOLERANCE DECREASED 1 0.0001
760 HYPOGLYCAEMIA 6 0.0001
761 PRESYNCOPE 3 0.0001
762 ATRIAL FIBRILLATION 12 0.0001
763 GASTROINTESTINAL DISORDER 11 0.0001
764 DECUBITUS ULCER 1 0.0001
765 ASPHYXIA 1 0.0001
766 LIVER INJURY 3 0.0001
767 ENCEPHALOPATHY 3 0.0001
768 HICCUPS 1 0.0001
769 EYE DISORDER 4 0.0001
770 MANIA 2 0.0001
771 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
772 HEMIPLEGIA 1 0.0001
773 DYSPHONIA 7 0.0001
774 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
775 PAIN 73 0.0001
776 SWELLING 11 0.0001
777 HAEMATOMA 3 0.0001
778 BLOOD CALCIUM INCREASED 1 0.0001
779 PANCREATITIS 6 0.0001
780 SLEEP DISORDER 8 0.0001
781 LYMPHOCYTE COUNT DECREASED 2 0.0001
782 GASTROINTESTINAL INFECTION 1 0.0001
783 ANAL INCONTINENCE 1 0.0001
784 PERIPHERAL SWELLING 17 0.0001
785 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
786 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
787 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
788 THINKING ABNORMAL 2 0.0001
789 HEPATIC ENCEPHALOPATHY 1 0.0001
790 FLANK PAIN 1 0.0001
791 DYSARTHRIA 4 0.0001
792 BLOOD SODIUM DECREASED 2 0.0001
793 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
794 SEROTONIN SYNDROME 2 0.0001
795 LOWER LIMB FRACTURE 2 0.0001
796 ATELECTASIS 1 0.0001
797 DIZZINESS POSTURAL 1 0.0001
798 CHEST PAIN 19 0.0001
799 SURGERY 6 0.0001
800 RESPIRATORY DISORDER 3 0.0001
801 CYTOKINE RELEASE SYNDROME 2 0.0001
802 DEVICE MALFUNCTION 7 0.0001
803 GAIT DISTURBANCE 19 0.0001
804 EYELID PTOSIS 1 0.0001
805 DRY THROAT 1 0.0001
806 BODY TEMPERATURE INCREASED 2 0.0001
807 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
808 LIMB DISCOMFORT 3 0.0001
809 FEMUR FRACTURE 3 0.0001
810 POLLAKIURIA 4 0.0001
811 DERMATITIS 2 0.0001
812 PARAESTHESIA 15 0.0001
813 DEPRESSED MOOD 5 0.0001
814 FULL BLOOD COUNT ABNORMAL 1 0.0001
815 METABOLIC ACIDOSIS 3 0.0001
816 HYPOAESTHESIA 14 0.0001
817 POOR QUALITY SLEEP 2 0.0001
818 ASPIRATION 1 0.0001
819 MELAENA 2 0.0001
820 VIRAL INFECTION 3 0.0001
821 RASH MACULO-PAPULAR 2 0.0001
822 DRY SKIN 12 0.0001
823 URTICARIA 15 0.0001
824 ORAL PAIN 2 0.0001
825 EYE INFECTION 1 0.0001
826 PRODUCT DOSE OMISSION ISSUE 26 0.0001
827 MUSCULAR WEAKNESS 10 0.0001
828 LETHARGY 5 0.0001
829 DRUG INEFFECTIVE 114 0.0001
830 RENAL DISORDER 4 0.0001
831 HYPERKALAEMIA 3 0.0001
832 HYPERHIDROSIS 11 0.0001
833 PAIN IN EXTREMITY 25 0.0001
834 CARDIAC ARREST 7 0.0001
835 BLOOD IRON DECREASED 1 0.0001
836 CATARACT 5 0.0001
837 RASH ERYTHEMATOUS 4 0.0001
838 ABDOMINAL DISCOMFORT 14 0.0001
839 RENAL IMPAIRMENT 7 0.0001
840 HEPATIC CANCER 2 0.0001
841 TOXICITY TO VARIOUS AGENTS 14 0.0001
842 DRUG INTOLERANCE 8 0.0001
843 ERYTHEMA 17 0.0001
844 ADRENAL INSUFFICIENCY 1 0.0001
845 MYALGIA 14 0.0001
846 ACCIDENTAL OVERDOSE 3 0.0001
847 FEELING HOT 5 0.0001
848 HEADACHE 51 0.0001
849 OSTEONECROSIS OF JAW 2 0.0001
850 INFLUENZA 9 0.0001
851 CONFUSIONAL STATE 13 0.0001
852 DERMATITIS ALLERGIC 1 0.0001
853 ARTHRALGIA 33 0.0001
854 HAEMATEMESIS 2 0.0001
855 THERAPY CESSATION 4 0.0001
856 SWELLING FACE 5 0.0001
857 CEREBROVASCULAR ACCIDENT 13 0.0001
858 DEAFNESS 2 0.0001
859 ADVERSE EVENT 7 0.0001
860 PRURITUS 29 0.0001
861 EYE HAEMORRHAGE 1 0.0001
862 OEDEMA 4 0.0001
863 MOOD ALTERED 2 0.0001
864 GINGIVAL BLEEDING 1 0.0001
865 HAEMATOCHEZIA 4 0.0001
866 TREATMENT FAILURE 6 0.0001
867 FEELING COLD 2 0.0001
868 HUNGER 1 0.0001
869 COORDINATION ABNORMAL 1 0.0001
870 APHONIA 1 0.0001
871 NECK PAIN 4 0.0001
872 FLATULENCE 4 0.0001
873 DIALYSIS 1 0.0001
874 RECTAL HAEMORRHAGE 3 0.0001
875 MOBILITY DECREASED 5 0.0001
876 NASAL CONGESTION 4 0.0001
877 ACUTE MYOCARDIAL INFARCTION 2 0.0001
878 CARDIOMYOPATHY 1 0.0001
879 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
880 RENAL INJURY 2 0.0001
881 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
882 HOT FLUSH 5 0.0001
883 HYPOAESTHESIA ORAL 1 0.0001
884 TREMOR 11 0.0001
885 BLOOD COUNT ABNORMAL 1 0.0001
886 DEPRESSION 15 0.0001
887 INCORRECT DOSE ADMINISTERED 15 0.0001
888 DIABETES MELLITUS 5 0.0001
889 VISION BLURRED 9 0.0001
890 MEMORY IMPAIRMENT 9 0.0001
891 SKIN DISCOLOURATION 3 0.0001
892 VISUAL IMPAIRMENT 8 0.0001
893 FALL 21 0.0001
894 COMA 3 0.0001
895 ABSCESS 1 0.0001
896 CONDITION AGGRAVATED 19 0.0001
897 LOSS OF CONSCIOUSNESS 8 0.0001
898 HIP FRACTURE 2 0.0001
899 RHINORRHOEA 4 0.0001
900 DRY EYE 3 0.0001
901 FUNGAL INFECTION 2 0.0001
902 NEOPLASM MALIGNANT 4 0.0001
903 PALPITATIONS 7 0.0001
904 ANGER 2 0.0001
905 FLUID RETENTION 3 0.0001
906 HAEMATURIA 2 0.0001
907 BLOOD GLUCOSE INCREASED 11 0.0001
908 GASTRIC DISORDER 2 0.0001
909 INFLAMMATION 3 0.0001
910 BALANCE DISORDER 5 0.0001
911 DELIRIUM 2 0.0001
912 HAEMORRHAGE 6 0.0001
913 AMENORRHOEA 1 0.0001
914 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
915 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
916 BONE DISORDER 1 0.0001
917 FEELING ABNORMAL 13 0.0001
918 CONJUNCTIVITIS 1 0.0001
919 HEPATIC STEATOSIS 1 0.0001
920 HALLUCINATION 4 0.0001
921 ANXIETY 15 0.0001
922 BLOOD URINE PRESENT 1 0.0001
923 GASTRIC ULCER 1 0.0001
924 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
925 HERNIA 1 0.0001
926 ERUCTATION 1 0.0001
927 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
928 DRUG INTERACTION 8 0.0001
929 COMPLICATION OF DEVICE INSERTION 1 0.0001
930 OEDEMA PERIPHERAL 6 0.0000
931 BLINDNESS 2 0.0000
932 DEEP VEIN THROMBOSIS 3 0.0000
933 FAECES DISCOLOURED 1 0.0000
934 MENTAL DISORDER 2 0.0000
935 COLITIS ULCERATIVE 2 0.0000
936 PULMONARY OEDEMA 2 0.0000
937 ADVERSE DRUG REACTION 4 0.0000
938 MUSCLE SPASMS 8 0.0000
939 TINNITUS 2 0.0000
940 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
941 CARDIAC DISORDER 4 0.0000
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
944 DIABETIC KETOACIDOSIS 1 0.0000
945 FIBROMYALGIA 1 0.0000
946 UNDERDOSE 3 0.0000
947 AGGRESSION 2 0.0000
948 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
949 EXPOSURE VIA SKIN CONTACT 1 0.0000
950 INSOMNIA 10 0.0000
951 HAEMOPTYSIS 1 0.0000
952 DEMENTIA 1 0.0000
953 BLISTER 2 0.0000
954 DYSSTASIA 1 0.0000
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
956 WHEEZING 2 0.0000
957 NO ADVERSE EVENT 6 0.0000
958 APHASIA 1 0.0000
959 BLOOD PRESSURE INCREASED 5 0.0000
960 HOSPITALISATION 5 0.0000
961 HEAD INJURY 1 0.0000
962 CONTUSION 3 0.0000
963 IMPAIRED HEALING 1 0.0000
964 SINUSITIS 3 0.0000
965 DEVICE USE ERROR 1 0.0000
966 BURNING SENSATION 2 0.0000
967 OVERDOSE 6 0.0000
968 BRONCHITIS 2 0.0000
969 EYE SWELLING 1 0.0000
970 ACNE 2 0.0000
971 ARTHRITIS 2 0.0000
972 EXTRA DOSE ADMINISTERED 1 0.0000
973 INFLUENZA LIKE ILLNESS 2 0.0000
974 HYPOACUSIS 1 0.0000
975 DEVICE DISLOCATION 1 0.0000
976 MYOCARDIAL INFARCTION 4 0.0000
977 MUSCULOSKELETAL STIFFNESS 2 0.0000
978 ANGIOEDEMA 1 0.0000
979 DEVICE ISSUE 2 0.0000
980 BLOOD GLUCOSE DECREASED 1 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
982 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
983 ECZEMA 1 0.0000
984 BRADYCARDIA 1 0.0000
985 DISTURBANCE IN ATTENTION 1 0.0000
986 EYE PAIN 1 0.0000
987 RHEUMATOID ARTHRITIS 2 0.0000
988 AMNESIA 1 0.0000
989 AGITATION 1 0.0000
990 DRUG WITHDRAWAL SYNDROME 1 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
992 ASTHMA 1 0.0000
993 EMOTIONAL DISTRESS 1 0.0000